Fluticasone vs Montelukast

For allergic rhinitis, intranasal corticosteroids like fluticasone are considered the most effective single-agent treatment. Clinical guidelines from the American Academy of Allergy, Asthma & Immunology recommend them as first-line therapy. Fluticasone effectively treats all major nasal allergy symptoms: congestion, sneezing, runny nose, and itching.

Montelukast is less effective than intranasal corticosteroids for nasal symptoms overall, particularly nasal congestion. However, it provides systemic relief that can also help with itchy/watery eyes (which nasal sprays do not directly address) and lower airway symptoms in patients with concurrent asthma.

For patients with both allergic rhinitis and asthma, montelukast can address both conditions with a single oral medication. Adding montelukast to fluticasone may provide additional benefit for patients with incomplete response to the nasal spray alone.

Fluticasone nasal spray is generally well tolerated. Common side effects include nasal irritation, nosebleeds (epistaxis in 5-10% of users), headache, and sore throat. Long-term use at recommended doses is considered safe, with minimal systemic corticosteroid absorption. Rarely, nasal septal perforation can occur with improper spray technique.

Montelukast carries an FDA boxed warning (added in 2020) for serious neuropsychiatric events including agitation, depression, sleep disturbances, suicidal thinking, and hallucinations. These events are rare but can be severe. The FDA recommends that healthcare providers consider the benefits and risks before prescribing montelukast, and that patients be monitored for mood or behavior changes.

This boxed warning has significantly changed prescribing patterns, with many doctors now reserving montelukast for patients who have not responded to or cannot use first-line treatments.

Fluticasone nasal spray is available over the counter (Flonase) for approximately $15-$25 per bottle (about a one-month supply). Generic store-brand versions are even cheaper. No prescription or insurance is needed.

Generic montelukast costs approximately $10-$25 per month with insurance. Without insurance, the generic is still affordable at $15-$40 per month. However, it requires a doctor visit and prescription.

Fluticasone requires daily nasal spraying (1-2 sprays per nostril), which some patients find inconvenient or unpleasant. Proper technique is important for effectiveness and to minimize nosebleeds. It works best with regular daily use rather than as needed.

Montelukast is a once-daily oral tablet, which many patients find simpler and more acceptable. It comes in chewable tablets for children and granule packets for young children, making pediatric dosing straightforward.

For most patients with allergic rhinitis, fluticasone nasal spray should be tried first. It is the most effective single treatment for nasal allergy symptoms, is available without a prescription, and has a strong safety profile.

Montelukast may be considered if you cannot tolerate nasal sprays, if you also have asthma (allowing one medication for both conditions), or if fluticasone alone provides insufficient relief. However, the FDA boxed warning for neuropsychiatric effects means montelukast should not be used casually for mild allergies when effective alternatives exist.

Always discuss new or worsening mood symptoms with your doctor if you start montelukast.